News | March 22, 2022
Hester Biosciences foray into pet care industry
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
The company plans to launch the product immediately
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
The drug is indicated for use in combination with other drugs
Subscribe To Our Newsletter & Stay Updated
